Share on StockTwits

Genpact Limited (NYSE:G) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Tuesday, Analyst Ratings Network.com reports. The firm currently has a $18.50 target price on the stock. Zacks‘s target price suggests a potential upside of 8.50% from the stock’s previous close.

Genpact Limited (NYSE:G) traded up 0.65% during mid-day trading on Tuesday, hitting $17.05. 782,929 shares of the company’s stock traded hands. Genpact Limited has a 1-year low of $13.68 and a 1-year high of $21.30. The stock’s 50-day moving average is $17.05 and its 200-day moving average is $17.41. The company has a market cap of $3.979 billion and a price-to-earnings ratio of 17.30. Genpact Limited also was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 2,467,333 shares, a decline of 54.4% from the April 15th total of 5,412,777 shares. Based on an average daily trading volume, of 545,132 shares, the short-interest ratio is presently 4.5 days. Currently, 1.4% of the shares of the stock are short sold.

Genpact Limited (NYSE:G) last issued its quarterly earnings data on Monday, May 5th. The company reported $0.24 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.23 by $0.01. The company had revenue of $528.20 million for the quarter, compared to the consensus estimate of $527.07 million. During the same quarter last year, the company posted $0.23 earnings per share. Genpact Limited’s revenue was up 4.8% compared to the same quarter last year. On average, analysts predict that Genpact Limited will post $1.04 earnings per share for the current fiscal year.

A number of other firms have also recently commented on G. Analysts at Morgan Stanley reiterated an “equal weight” rating on shares of Genpact Limited in a research note on Tuesday, May 6th. They now have a $18.00 price target on the stock. Separately, analysts at BMO Capital Markets upgraded shares of Genpact Limited from a “market perform” rating to an “outperform” rating in a research note on Monday, February 24th. They now have a $18.00 price target on the stock. Finally, analysts at Piper Jaffray initiated coverage on shares of Genpact Limited in a research note on Thursday, February 20th. They set an “overweight” rating and a $18.00 price target on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $17.79.

Genpact Limited (NYSE:G) is engaged in business process management and information technology services, leveraging the power of processes, analytics and technology to help its clients drive intelligence across their enterprises.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.